The PI3K/Akt signaling pathway promotes GBM progression, and its activation has been associated with treatment resistance and poor prognosis in GBM patients; GSK3-β is a component of the PI3K/Akt signaling pathway [361]. Here, GSK3B is linked to glioblastoma.